Achieve Life Sciences
ACHV
56 hedge funds and large institutions have $78.4M invested in Achieve Life Sciences in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 9 closing their positions.
2,205% more call options, than puts
Call options by funds: $2.67M | Put options by funds: $116K
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
37% more funds holding
Funds holding: 41 → 56 (+15)
21% more capital invested
Capital invested by funds: $64.9M → $78.4M (+$13.5M)
6.04% more ownership
Funds ownership: 48.06% → 54.1% (+6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$9.17M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.68M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.38M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.68M |
| 5 |
Bank of New York Mellon
New York
|
+$494K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$2.98M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.39M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$1.6M |
| 4 |
Millennium Management
New York
|
-$845K |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$626K |
ACHV Hedge Fund Activity: Q2 2024 in Review
56 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2024, worth a combined $78.4M — up 21% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ACHV positions and 9 closed out — a net gain of 15 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $9.17M. The largest seller was Altium Capital Management, cutting an estimated $2.98M.
- 56 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2024, up from 41 in Q1 2024.
- Funds reported $78.4M of Achieve Life Sciences stock for Q2 2024, up 21% quarter-over-quarter.
- 24 funds opened new Achieve Life Sciences positions in Q2 2024 and 9 closed out, a net change of +15 holders.
- The largest Achieve Life Sciences buyer in Q2 2024 was BlackRock, an estimated $9.17M added.
- The largest Achieve Life Sciences seller in Q2 2024 was Altium Capital Management, an estimated $2.98M sold.
Based on aggregated 13F filings for Q2 2024.